Abstract

Background and purposePrimary rectal squamous cell carcinoma (SCC) is an uncommon disease. Early reports stated that surgery is the most effective treatment. However, recent publications suggest conservative strategy with chemoradiation provides satisfactory results. Patients and methodsWe have retrospectively studied the medical charts of 23 patients treated for a rectal SCC in two teaching hospitals in France between 1992 and 2013. Twenty-one patients received an exclusive chemoradiotherapy (CRT) and two a pre-operative CRT followed by a planned surgery. Patients received pelvic irradiation with a dose ranging from 36–45 Gy followed by a boost of 15–23 Gy. Twenty-two patients received a concurrent chemotherapy. ResultsAfter CRT, the rate of clinical complete response was 83%. With a median follow-up of 85 months, 5-year overall survival rate was 86%. Five patients presented with a relapse. The 5-year disease-free survival rate was 81%. The 5-year colostomy-free survival rate was 65%. Three patients (13%) presented with grade III–IV late rectal toxicity. ConclusionsAlthough retrospective, this is the largest cohort of patients treated with CRT for a rectal SCC. Exclusive CRT could result in high local control rate and prolonged survival in rectal SCC patients with a high rate of organ preservation.

Highlights

  • Colorectal carcinoma is the third leading cause of death due to cancer worldwide

  • Rectal squamous cell carcinoma (SCC) is an orphan disease with the four largest cases series reported by MSKCC [10], M.D

  • Several concurrent chemotherapy regimens were given to our patients but mostly consisted of 5FU and cisplatin that was the preferred regimen in France for anal SCC before the final results of Intergroup RTOG 9811 phase III trial [23]

Read more

Summary

Introduction

Squamous cell carcinoma (SCC) is an extremely rare subtype accounting for 0.1 to 0.25% of colorectal tumours. Radical surgery is limited to patients without response after CRT or at the time of relapse. This retrospective study aims to assess the outcome of patients with rectal SCC treated with CRT in two French university hospitals. Primary rectal squamous cell carcinoma (SCC) is an uncommon disease. Conclusions: retrospective, this is the largest cohort of patients treated with CRT for a rectal SCC. Exclusive CRT could result in high local control rate and prolonged survival in rectal SCC patients with a high rate of organ preservation

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.